1. <cite id="vrzoi"></cite>

      <noscript id="vrzoi"></noscript>
    2. <output id="vrzoi"></output>
      超清无码一区二区三区
      1. <cite id="vrzoi"></cite>

        <noscript id="vrzoi"></noscript>
      2. <output id="vrzoi"></output>
        Montelukast API and its key intermediates USP
        Rivaroxaban API and its key intermediates USP
        Ticagrelaor API and its key intermediates USP
        Ezetimibe API and its key intermediates USP
        Capecitabine API and its key intermediates USP
        Sitagliptin API and its key intermediates USP
        More>>      
        Arromax Pharmatech Co., Ltd.
        Add: BIdg 6,No.1 Huayun Road,
        Sangtiandao Science Innovation Park
        Tel: +86-512-62956319
        Sales hotline: +86-512-62959601
                                  +86-15995748448
        Fax: +86-512-62956319-8015
        Arromax Pharmatech Indian Office
        Add: Kolkata, India
        Url: http://www.am55388.com/

        Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. is a high-tech enterprise founded by returning students, located at Sangtian Island Innovation Park in the high-tech industrial zone-Suzhou Industrial Park (SIP), Suzhou. SIP is developed jointly by the Chinese government and the Singapore government.
        The company is engaged in targeted anti-tumor drug discovery and generic drug synthesis, innovation process development. The company provides innovative discovery services of new clinical candidate to domestic and foreign pharmaceutical companies, including anti-tumor, cardiovascular, central nervous system, anti-infection and other fields of therapeutic drugs. It provides process development and synthesis of high-quality APIs and their intermediates.
        Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. has experienced R & D team and been recognized and supported by the scientific communities. The company applies cutting-edge technology in the fields of organic chemistry, pharmaceutical chemistry, pharmacological toxicology, etc., focusing on research and development of the world's leading innovative drugs and innovative synthesis processes with independent intellectual property rights.
        Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. has won the "national high-tech enterprises", "Jiangsu province private Science and technology enterprises", "Jiangsu Province Science and technology small and medium-sized enterprises", "Suzhou small molecular New drug R & amp; d Engineering Technology Center", "Suzhou Leading talent Enterprise" Suzhou Industrial Park Science and technology leading talent enterprise "and other qualification titles.
        Independent innovation is the primary pursuit of Arromax medicine. To make positive contributions to China's drug innovation and research and development is the goal of Arromax Pharmaceutical Technology (Suzhou) Co., Ltd. The enterprise mission of Arromax is to "bring good human health, by the innovation ability, realize self-worth, assume social responsibility".
        Our Enterprise vision is " To build the world's top drug innovation R & D technology center and well-known brands". Our spirit is "unity, hard work and true-seeking, innovation"
        “Mutual benefit and win” is our business philosophy.

        Home | About Us | www.en-cphi.cn | R & D | Technology transfer | Products | Contact | 中文版???【Admin login】
        Copyright(C)2013, Arromax Pharmatech Co., Ltd. All Rights Reserved.Supported by ChemNet ChinaChemNet Toocle Copyright Notice???[ Admin login ]